Financials data is unavailable for this security.
View more
Year on year P3 Health Partners Inc grew revenues 20.67% from 1.05bn to 1.27bn. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -270.13m to -57.77m.
| Gross margin | 0.62% |
|---|---|
| Net profit margin | -13.17% |
| Operating margin | -12.35% |
| Return on assets | -20.51% |
|---|---|
| Return on equity | -453.01% |
| Return on investment | -110.70% |
More ▼
Cash flow in USDView more
In 2023, P3 Health Partners Inc increased its cash reserves by 121.78%, or 22.48m. Cash Flow from Financing totalled 100.33m or 7.92% of revenues. In addition the company used 76.03m for operations while cash used for investing totalled 1.83m.
| Cash flow per share | -0.8095 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 1.03 |
|---|---|
| Tangible book value per share | -2.83 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.6873 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.8029 |
|---|---|
| Total debt/total capital | 0.2686 |
More ▼
